Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie A Kleinschek

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Immunology|April 17, 2014
IL-25 exhibits disparate roles during Th2-cell differentiation versus effector functionHelen Mearns, Elizabeth E Forbes-Blom, Mali Camberis, et al.
International Immunology|December 3, 2009
Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infectionMelanie A Kleinschek, Uwe Müller, Nicole Schütze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12Melanie A Kleinschek, Uwe Muller, Scott J Brodie, et al.
The Journal of Clinical Investigation|May 4, 2006
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6David Yen, Jeanne Cheung, Heleen Scheerens, et al.
Nature|March 5, 2010
IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responsesSteven A Saenz, Mark C Siracusa, Jacqueline G Perrigoue, et al.
The Journal of Experimental Medicine|January 4, 2007
IL-25 regulates Th17 function in autoimmune inflammationMelanie A Kleinschek, Alexander M Owyang, Barbara Joyce-Shaikh, et al.
The Journal of Experimental Medicine|March 11, 2009
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammationMelanie A Kleinschek, Katia Boniface, Svetlana Sadekova, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2015
Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modificationsJongwon Lim, Michael D Altman, James Baker, et al.
Journal of Crohn'S & Colitis|March 13, 2020
Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine ProgrammeWilliam J Sandborn, Deanna D Nguyen, David T Beattie, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4Jongwon Lim, Michael D Altman, James Baker, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Immunology|April 17, 2014
IL-25 exhibits disparate roles during Th2-cell differentiation versus effector functionHelen Mearns, Elizabeth E Forbes-Blom, Mali Camberis, et al.
International Immunology|December 3, 2009
Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infectionMelanie A Kleinschek, Uwe Müller, Nicole Schütze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12Melanie A Kleinschek, Uwe Muller, Scott J Brodie, et al.
The Journal of Clinical Investigation|May 4, 2006
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6David Yen, Jeanne Cheung, Heleen Scheerens, et al.
Nature|March 5, 2010
IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responsesSteven A Saenz, Mark C Siracusa, Jacqueline G Perrigoue, et al.
The Journal of Experimental Medicine|January 4, 2007
IL-25 regulates Th17 function in autoimmune inflammationMelanie A Kleinschek, Alexander M Owyang, Barbara Joyce-Shaikh, et al.
The Journal of Experimental Medicine|March 11, 2009
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammationMelanie A Kleinschek, Katia Boniface, Svetlana Sadekova, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2015
Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modificationsJongwon Lim, Michael D Altman, James Baker, et al.
Journal of Crohn'S & Colitis|March 13, 2020
Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine ProgrammeWilliam J Sandborn, Deanna D Nguyen, David T Beattie, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4Jongwon Lim, Michael D Altman, James Baker, et al.
Pageof 2